|
|
DSpace at RU >
Browsing by Author Vulto, A.G.
Showing results 1 to 10 of 10
| Full Text | Issue Date | Title | Author(s) | | 2006 | Treatment of metastatic renal cell carcinoma with autologous T-lymphocytes genetically retargeted against carbonic anhydrase IX: first clinical experience. | Lamers, C.H.; Sleijfer, S.; Vulto, A.G.; Kruit, W.; Kliffen, M., et al |
| 2005 | An additional measure for quantifying antibiotic use in hospitals. | Filius, P.M.; Liem, T.B.; Linden, P.D. van der; Janknegt, R.; Natsch, S.S., et al |
| 2005 | Changes in antibiotic use in Dutch hospitals over a six-year period: 1997 to 2002. | Liem, T.B.; Filius, F.M.; Linden, P.D. van der; Janknegt, R.; Natsch, S.S., et al |
| 2005 | Imipramine dose in relation to therapeutic plasma level: are clinical trials using imipramine as a positive control flawed? | Birkenhäger, T.K.; Broek, W.W. van den; Moleman, P.; Vulto, A.G.; Bruijn, J.A. |
| 2005 | Allelic variants of cytochrome P450 2C9 modify the interaction between nonsteroidal anti-inflammatory drugs and coumarin anticoagulants. | Visser, L.E.; Schaik, R.H. van; Vliet, M. van; Trienekens, P.H.; Smet, P.A.G.M. de, et al |
| 2005 | Patients with an ApoE epsilon4 allele require lower doses of coumarin anticoagulants. | Visser, L.E.; Trienekens, P.H.; Smet, P.A.G.M. de; Vulto, A.G.; Hofman, A., et al |
| 2004 | Long-term intravenous treatment of Pompe disease with recombinant human alpha-glucosidase from milk. | Hout, J.M. van den; Kamphoven, J.H.; Winkel, L.P.; Arts, W.F.M.; Klerk, J.B.C. de, et al |
| 2004 | Overanticoagulation associated with combined use of lactulose and coumarin anticoagulants. | Visser, L.E.; Penning-van Beest, F.J.A.; Wilson, J.H.; Vulto, A.G.; Kasbergen, A.A.H., et al |
| 2004 | The risk of overanticoagulation in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. | Visser, L.E.; Vliet, M. van; Schaik, R.H. van; Kasbergen, A.A.H.; Smet, P.A.G.M. de, et al |
| 2004 | The risk of bleeding complications in patients with cytochrome P450 CYP2C9*2 or CYP2C9*3 alleles on acenocoumarol or phenprocoumon. | Visser, L.E.; Schaik, R.H. van; Vliet, M. van; Trienekens, P.H.; Smet, P.A.G.M. de, et al |
Showing results 1 to 10 of 10
|